Mather Group LLC. Buys 127 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Mather Group LLC. boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.6% during the third quarter, HoldingsChannel reports. The fund owned 1,059 shares of the biopharmaceutical company’s stock after purchasing an additional 127 shares during the quarter. Mather Group LLC.’s holdings in Regeneron Pharmaceuticals were worth $872,000 at the […]

Related Keywords

Canada ,Michaels Brown ,Josephl Goldstein ,Raymond James ,Benjaminf Edwards Company Inc ,Regeneron Pharmaceuticals Inc ,Regeneron Pharmaceuticals Stock Performance ,News Ratings For Regeneron Pharmaceuticals Daily ,Sunbelt Securities Inc ,Sutton Wealth Advisors Inc ,Mather Group ,Securities Exchange Commission ,Regeneron Pharmaceuticals ,Nasdaq ,Annis Gardner Whiting Capital Advisors ,Milestone Investment Advisors ,Cantor Fitzgerald ,Regeneron Pharmaceuticals Profile ,Royal Bank ,Barclays ,Insider Activity At Regeneron Pharmaceuticals ,Quarter For Regeneron Pharmaceuticals ,Free Report ,Gardner Whiting Capital Advisors ,Wealth Advisors ,Director Joseph ,Exchange Commission ,Director Michael ,Get Free Report ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,